AL
Alibaba Health Information Technology Limited
ALBHF · OTC
$0.40 +2.56% (+$0.01)
1M -1.38%
Market Cap ¥42.3B
P/E Ratio 29.52x
Div. Yield 7.35%
ROE 8.43%
Bulios Fair Price
$0.37
7.5% downside
Current Price
$0.4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ALBHF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
45 /100
Fair P/B 2.59x
P/S 1.38x
P/E 29.52x
Growth
85 /100
Growing FCF growth 49.79%
Book val. growth 4.98%
Rev. growth 14.14%
Profitability
32 /100
Weak FCF margin 4.50%
Op. margin 5.15%
Gross margin 24.29%
Quality
55 /100
Average Asset turnover 1.44x
ROA 6.76%
ROIC 8.80%
Debt
100 /100
Low Net debt/EBITDA -1.35x
Int. coverage 598.92x
Debt/Equity 0.00x
Stability
36 /100
Moderate Profitable years 3
EPS volatility 145.18%
Beta 1.61x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALBHF
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Di Fan Shen
Employees
1,394
Headquarters
Hong Kong
Upcoming events
01 DEC
Earnings
Upcoming earnings report